A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance

In thyroid cancer patients with renal impairment or other complicating factors, it is important to maximize I-131 therapy efficacy while minimizing bone marrow and lung damage. We developed a web-based calculator based on a modified Benua and Leeper method to calculate the maximum I-131 dose to redu...

Full description

Saved in:
Bibliographic Details
Published in:SAGE open medical case reports 2017, Vol.5, p.2050313X17745203
Main Authors: Howard, Brandon A, James, Olga G, Perkins, Jennifer M, Pagnanelli, Robert A, Borges-Neto, Salvador, Reiman, Robert E
Format: Article
Language:English
Subjects:
Case Report
Case reports
Thyroid cancer
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3403-584e82601774019fe8a9a2e8faf0d3897cf405492b785e7f10a0e37493f976d03
cites cdi_FETCH-LOGICAL-c3403-584e82601774019fe8a9a2e8faf0d3897cf405492b785e7f10a0e37493f976d03
container_end_page
container_issue
container_start_page 2050313X17745203
container_title SAGE open medical case reports
container_volume 5
creator Howard, Brandon A
James, Olga G
Perkins, Jennifer M
Pagnanelli, Robert A
Borges-Neto, Salvador
Reiman, Robert E
description In thyroid cancer patients with renal impairment or other complicating factors, it is important to maximize I-131 therapy efficacy while minimizing bone marrow and lung damage. We developed a web-based calculator based on a modified Benua and Leeper method to calculate the maximum I-131 dose to reduce the risk of these toxicities, based on the effective renal clearance of I-123 as measured from two whole-body I-123 scans, performed at 0 and 24 h post-administration.
doi_str_mv 10.1177/2050313X17745203
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_000205d7943c4d4db1bfaf1b6aff3128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2050313X17745203</sage_id><doaj_id>oai_doaj_org_article_000205d7943c4d4db1bfaf1b6aff3128</doaj_id><sourcerecordid>2425594547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3403-584e82601774019fe8a9a2e8faf0d3897cf405492b785e7f10a0e37493f976d03</originalsourceid><addsrcrecordid>eNp1kctr3DAQxkVpacI2956KoGc3o4ct61IIoY-FQC8t9CZkabTrxWu5kjew-esrd5M0KfSk0afRbx4fIW8ZfGBMqUsONQgmfpZY1hzEC3K-SNWivXwSn5GLnHcAwEC3DYjX5IxrLrmSzTkZr-iUrJt7Zwe6x3kbPY2BrismGJ23xxR7T50dHaZyxWSnI_UxI43T3O_7Ozv3caSH3I8birlIdkZPMQQszFukCccCdgPatEDekFfBDhkv7s8V-fH50_frr9XNty_r66ubygkJoqpbiS1vYBkNmA7YWm05tsEG8KLVygUJtdS8U22NKjCwgEJJLYJWjQexIusT10e7M1MqfaWjibY3f4SYNsamMvSApiymrMorLYWTXvqOdaUM6xobgmC8LayPJ9Z06PboHY5zssMz6POXsd-aTbw1teKyKQ6syPt7QIq_DmVLZhcPqewlm2JDXWtZS1Wy4JTlUsw5YXiswMAshpt_DS9f3j3t7PHDg70loTolZLvBv1X_C_wN5l2yyA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425594547</pqid></control><display><type>article</type><title>A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance</title><source>SAGE Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Howard, Brandon A ; James, Olga G ; Perkins, Jennifer M ; Pagnanelli, Robert A ; Borges-Neto, Salvador ; Reiman, Robert E</creator><creatorcontrib>Howard, Brandon A ; James, Olga G ; Perkins, Jennifer M ; Pagnanelli, Robert A ; Borges-Neto, Salvador ; Reiman, Robert E</creatorcontrib><description>In thyroid cancer patients with renal impairment or other complicating factors, it is important to maximize I-131 therapy efficacy while minimizing bone marrow and lung damage. We developed a web-based calculator based on a modified Benua and Leeper method to calculate the maximum I-131 dose to reduce the risk of these toxicities, based on the effective renal clearance of I-123 as measured from two whole-body I-123 scans, performed at 0 and 24 h post-administration.</description><identifier>ISSN: 2050-313X</identifier><identifier>EISSN: 2050-313X</identifier><identifier>DOI: 10.1177/2050313X17745203</identifier><identifier>PMID: 29242746</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Case Report ; Case reports ; Thyroid cancer</subject><ispartof>SAGE open medical case reports, 2017, Vol.5, p.2050313X17745203</ispartof><rights>The Author(s) 2017</rights><rights>The Author(s) 2017. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://www.creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2017 2017 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3403-584e82601774019fe8a9a2e8faf0d3897cf405492b785e7f10a0e37493f976d03</citedby><cites>FETCH-LOGICAL-c3403-584e82601774019fe8a9a2e8faf0d3897cf405492b785e7f10a0e37493f976d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724631/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2425594547?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,21966,25753,27853,27923,27924,27925,37012,44590,44945,45333,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29242746$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Howard, Brandon A</creatorcontrib><creatorcontrib>James, Olga G</creatorcontrib><creatorcontrib>Perkins, Jennifer M</creatorcontrib><creatorcontrib>Pagnanelli, Robert A</creatorcontrib><creatorcontrib>Borges-Neto, Salvador</creatorcontrib><creatorcontrib>Reiman, Robert E</creatorcontrib><title>A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance</title><title>SAGE open medical case reports</title><addtitle>SAGE Open Med Case Rep</addtitle><description>In thyroid cancer patients with renal impairment or other complicating factors, it is important to maximize I-131 therapy efficacy while minimizing bone marrow and lung damage. We developed a web-based calculator based on a modified Benua and Leeper method to calculate the maximum I-131 dose to reduce the risk of these toxicities, based on the effective renal clearance of I-123 as measured from two whole-body I-123 scans, performed at 0 and 24 h post-administration.</description><subject>Case Report</subject><subject>Case reports</subject><subject>Thyroid cancer</subject><issn>2050-313X</issn><issn>2050-313X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kctr3DAQxkVpacI2956KoGc3o4ct61IIoY-FQC8t9CZkabTrxWu5kjew-esrd5M0KfSk0afRbx4fIW8ZfGBMqUsONQgmfpZY1hzEC3K-SNWivXwSn5GLnHcAwEC3DYjX5IxrLrmSzTkZr-iUrJt7Zwe6x3kbPY2BrismGJ23xxR7T50dHaZyxWSnI_UxI43T3O_7Ozv3caSH3I8birlIdkZPMQQszFukCccCdgPatEDekFfBDhkv7s8V-fH50_frr9XNty_r66ubygkJoqpbiS1vYBkNmA7YWm05tsEG8KLVygUJtdS8U22NKjCwgEJJLYJWjQexIusT10e7M1MqfaWjibY3f4SYNsamMvSApiymrMorLYWTXvqOdaUM6xobgmC8LayPJ9Z06PboHY5zssMz6POXsd-aTbw1teKyKQ6syPt7QIq_DmVLZhcPqewlm2JDXWtZS1Wy4JTlUsw5YXiswMAshpt_DS9f3j3t7PHDg70loTolZLvBv1X_C_wN5l2yyA</recordid><startdate>2017</startdate><enddate>2017</enddate><creator>Howard, Brandon A</creator><creator>James, Olga G</creator><creator>Perkins, Jennifer M</creator><creator>Pagnanelli, Robert A</creator><creator>Borges-Neto, Salvador</creator><creator>Reiman, Robert E</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>2017</creationdate><title>A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance</title><author>Howard, Brandon A ; James, Olga G ; Perkins, Jennifer M ; Pagnanelli, Robert A ; Borges-Neto, Salvador ; Reiman, Robert E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3403-584e82601774019fe8a9a2e8faf0d3897cf405492b785e7f10a0e37493f976d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Case Report</topic><topic>Case reports</topic><topic>Thyroid cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Howard, Brandon A</creatorcontrib><creatorcontrib>James, Olga G</creatorcontrib><creatorcontrib>Perkins, Jennifer M</creatorcontrib><creatorcontrib>Pagnanelli, Robert A</creatorcontrib><creatorcontrib>Borges-Neto, Salvador</creatorcontrib><creatorcontrib>Reiman, Robert E</creatorcontrib><collection>SAGE Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>SAGE open medical case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Howard, Brandon A</au><au>James, Olga G</au><au>Perkins, Jennifer M</au><au>Pagnanelli, Robert A</au><au>Borges-Neto, Salvador</au><au>Reiman, Robert E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance</atitle><jtitle>SAGE open medical case reports</jtitle><addtitle>SAGE Open Med Case Rep</addtitle><date>2017</date><risdate>2017</risdate><volume>5</volume><spage>2050313X17745203</spage><pages>2050313X17745203-</pages><issn>2050-313X</issn><eissn>2050-313X</eissn><abstract>In thyroid cancer patients with renal impairment or other complicating factors, it is important to maximize I-131 therapy efficacy while minimizing bone marrow and lung damage. We developed a web-based calculator based on a modified Benua and Leeper method to calculate the maximum I-131 dose to reduce the risk of these toxicities, based on the effective renal clearance of I-123 as measured from two whole-body I-123 scans, performed at 0 and 24 h post-administration.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>29242746</pmid><doi>10.1177/2050313X17745203</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2050-313X
ispartof SAGE open medical case reports, 2017, Vol.5, p.2050313X17745203
issn 2050-313X
2050-313X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_000205d7943c4d4db1bfaf1b6aff3128
source SAGE Open Access; Publicly Available Content Database; PubMed Central
subjects Case Report
Case reports
Thyroid cancer
title A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A21%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20practical%20method%20of%20I-131%20thyroid%20cancer%20therapy%20dose%20optimization%20using%20estimated%20effective%20renal%20clearance&rft.jtitle=SAGE%20open%20medical%20case%20reports&rft.au=Howard,%20Brandon%20A&rft.date=2017&rft.volume=5&rft.spage=2050313X17745203&rft.pages=2050313X17745203-&rft.issn=2050-313X&rft.eissn=2050-313X&rft_id=info:doi/10.1177/2050313X17745203&rft_dat=%3Cproquest_doaj_%3E2425594547%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3403-584e82601774019fe8a9a2e8faf0d3897cf405492b785e7f10a0e37493f976d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2425594547&rft_id=info:pmid/29242746&rft_sage_id=10.1177_2050313X17745203&rfr_iscdi=true